Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic taxane chemotherapy with valproic acid and enoxaparin in taxane-resistant metastatic solid tumors
ISRCTN27587187Phase 2Completed
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Apr 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel, docetaxel, valproic acid and enoxaparin in Nonhematologic neoplasms and Metastatic solid neoplasm (2 arms), sponsored by Seoul St. Mary's Hospital. Primary endpoint: Tumour marker decrease. Started Apr 2009; status: completed.
02
Drugs
paclitaxeldocetaxelvalproic acidenoxaparin
03
Conditions
Nonhematologic neoplasmsMetastatic solid neoplasm
Beyond the preview
Go deeper on ISRCTN27587187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN27587187.